{"id":"W4390614931","doi":"10.1097/meg.0000000000002690","title":"Effectiveness and safety of vedolizumab and infliximab in biologic-naive patients with Crohn’s disease: results from the EVOLVE study","year":2023,"lang":"en","type":"article","venue":"European Journal of Gastroenterology & Hepatology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Takeda (Canada); St. Paul's Hospital","funders":"","keywords":"Vedolizumab; Medicine; Infliximab; Internal medicine; Crohn's disease; Adverse effect; Incidence (geometry); Hazard ratio; Gastroenterology; Ulcerative colitis; Inflammatory bowel disease; Cumulative incidence; Surgery; Disease; Cohort; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003549137,0.0001830038,0.0008080682,0.0004334713,0.0001729143,0.0008009074,0.0002749038,0.0004393654,0.0006336219],"category_scores_gemma":[0.008314402,0.0001398277,0.0009405508,0.0006272999,0.0002576903,0.0004738317,0.0004703164,0.0003880879,0.0001019443],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006382713,"about_ca_system_score_gemma":0.0004801638,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001669571,"about_ca_topic_score_gemma":0.003092068,"domain_scores_codex":[0.9968582,0.001516995,0.0004200547,0.0003193044,0.0007528272,0.0001326084],"domain_scores_gemma":[0.9925891,0.002267601,0.003772742,0.0003251242,0.0005763857,0.0004690778],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.02279102,0.0006594139,0.9453867,0.0002580601,0.002049993,0.000109891,0.0001659449,0.0005048381,0.0006579161,0.00005268919,0.0003611008,0.02700258],"study_design_scores_gemma":[0.001640173,0.004411595,0.9906765,0.00005398066,0.0007849883,0.0002991015,0.0001330892,0.00058578,0.0003525902,0.00002067877,0.001027703,0.00001378809],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972448,0.00176834,0.0000515622,0.00005435935,0.000004685482,0.00002655463,0.0004166336,0.000002469739,0.000430738],"genre_scores_gemma":[0.9981874,0.0005265223,0.0001319612,0.00007221695,0.00002496315,0.00001923519,0.0009385801,0.000001793809,0.0000973376],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003549137,"threshold_uncertainty_score":0.01876992,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006425988158105275,"score_gpt":0.2146548563890618,"score_spread":0.2082288682309565,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}